Suggestions(1)
Exact(5)
It is the first drug shown in clinical trials to improve eyesight for a significant number of patients, as opposed to merely slowing the rate of vision loss.
Referral of eyes with DR to an ophthalmologist for further evaluation and treatment would aid in reducing the rate of vision loss, enabling timely and accurate diagnoses.
The lower rate of vision and hearing problems, arrhythmias, hypertension, varicosis and musculoskeletal diseases in our study matches this hypothesis.
Verteporfin PDT (Visudyne) was approved in 2000 following the demonstration that the procedure was effective in attenuating the rate of vision loss in AMD patients with classic containing lesions.
In clinical trials, pegaptanib was shown to have a modest effect in slowing the rate of vision loss in patients with wet AMD, while ranibizumab has proven to be highly effective not only in reducing macular edema and preventing further vision loss, but also in producing clinically meaningful improvements in vision in significant numbers of patients [ 26, 29, 30].
Similar(55)
Each of the 17 measures assessed various vision-related QoL dimensions using ratings from four concepts: difficulty (e.g. reading small print); frequency (e.g. times worrying about worsening eyesight in past month); severity (e.g. pain or discomfort in and around eyes); and global ratings (e.g. global rating of vision).
To identify determinants of adverse outcomes in acute retinal necrosis (ARN), presenting characteristics and incidence rates of vision loss and ocular complications in a cohort of polymerase chain reaction (PCR -positive eyes were analyzed.
Conversely, difficulties without glasses, vision satisfaction with glasses, and better rating of vision with glasses would reflect more dependence on glasses, i.e. less independence.
Delays in diagnosis lead to increased rates of vision loss, need for therapy intensification (with its associated life-time toxicity) and death, particularly for children who live in resource-poor settings [ 7].
For example, Alabama's population includes a large proportion (approximately 26%) of African Americans, and previous research indicates that rates of vision impairment and eye disease among African Americans are two times higher than those of whites, especially uncorrected refractive error, cataract, and diabetic retinopathy [ 5- 7].
Vitrectomy decreased the rate of severe vision loss from 47% (tap group) to 20% (vitrectomy group) in patients who presented with the worst vision (light perception only).
Write better and faster with AI suggestions while staying true to your unique style.
Since I tried Ludwig back in 2017, I have been constantly using it in both editing and translation. Ever since, I suggest it to my translators at ProSciEditing.

Justyna Jupowicz-Kozak
CEO of Professional Science Editing for Scientists @ prosciediting.com